eHealth Psychosocial Intervention for Parents of Children with Pediatric Cancer
Trial Summary
What is the purpose of this trial?
It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) with study endpoints focused on decreasing negative psychosocial sequelae (acute distress, posttraumatic stress, and anxiety) and improving coping abilities (coping self-efficacy, cognitive coping strategies). The long-term goal of this research program is to sustain and disseminate an effective, scalable, high-reach, and cost-effective intervention to provide crucial support to PCCC across the pediatric cancer trajectory.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Coping Space, eSCCIP/eSCCIP-SP, Electronic Surviving Cancer Competently Intervention Program, eSCCIP-SP for parents of children with pediatric cancer?
The eSCCIP program, which includes web-based content and telehealth sessions, has shown promise in reducing symptoms of distress and anxiety in parents of children with cancer, as well as improving family functioning. A similar program, SCCIP, demonstrated decreased posttraumatic stress and anxiety in families of adolescent cancer survivors, suggesting potential benefits for eSCCIP as well.12345
Is the eHealth Psychosocial Intervention for Parents of Children with Pediatric Cancer safe?
The eHealth Psychosocial Intervention, known as eSCCIP, has been tested in various studies and is generally considered safe for parents of children with cancer. It focuses on providing support through digital content and telehealth sessions, and no safety concerns have been reported in the available research.12345
How is the eSCCIP/eSCCIP-SP treatment different from other treatments for parents of children with pediatric cancer?
The eSCCIP/eSCCIP-SP treatment is unique because it is a digital health intervention specifically designed for parents of children with cancer, combining self-guided web-based content with telehealth sessions, making it more accessible and flexible compared to traditional in-person psychosocial care.12346
Eligibility Criteria
This trial is for English or Spanish speaking parents or primary caregivers of children (ages 0-18) diagnosed with cancer. They must have internet access via a computer or mobile device. Parents whose child may not survive beyond six months are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants engage in the eSCCIP/eSCCIP-SP program, which includes three 30-minute self-directed online modules and three telehealth follow-up sessions
Follow-up
Participants are monitored for reductions in acute distress, posttraumatic stress, and anxiety, and improvements in coping abilities
Treatment Details
Interventions
- Coping Space (Behavioral Intervention)
- eSCCIP/eSCCIP-SP (Behavioral Intervention)